Key facts
- Thesis Care’s last known valuation is $231.0M (Mar 2026).
- It has raised $60.0M; the latest was Early Stage VC ($45.0M) in Mar 2026.
- Notable investors include CRV, Oak HC/FT, Black Opal Ventures.
- Status: Privately Held (backing).
Investors
3- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Thesis Care
- ·The full record, as it builds
Funding rounds
No funding rounds for Thesis Care are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Thesis Care
Developer of an artificial intelligence-powered healthcare operations system designed to support scalable clinical capacity across care delivery organizations. The company's platform integrates automated agents with licensed clinical staff to execute care management and administrative workflows end to end, including patient outreach, clinical documentation, task completion, escalation handling, audit logging, role based access controls, and interoperability with existing clinical and operational systems, enabling healthcare providers, health systems, and care teams to increase operational throughput, reduce nonclinical workload, and extend care delivery capacity without altering established workflows.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2024
- Employees
- 33
- Website
- thesis.care/
- Ownership
- Privately Held (backing)
Thesis Care doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Thesis Care shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Thesis Care in its N-PORT filings yet. We sweep new filings monthly.